Trimethoprim: Clinical Trials

12 trials of Trimethoprim, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 2 terminated, 2 unknown, 1 active not recruiting. 12 Phase 2, 3 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 212Completed 4, Terminated 2, Unknown 2, Active not recruiting 1, Not yet recruiting 1, Recruiting 1, Withdrawn 1
Phase 13Active not recruiting 1, Completed 1, Withdrawn 1
Phase 31Terminated 1

Follow Trimethoprim: new trials by email Literature Review of Trimethoprim trials Research Report on Trimethoprim

Trials (filtered) newest first · largest first

All 12 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Folate Study in Men With Advanced Prostate Cancer
Trimethoprim Tablets - Prostate Cancer
Phase 2Not yet recruitingUniversity of California, San Diego502026-06-012025-11-12
Single Dose Aminoglycosides for Acute Uncomplicated Cystitis in the Emergency Department Setting
Gentamicin, Standard of Care - Urinary Tract Infections
Phase 2UnknownMercy Health Ohio1602022-10-012023-01-27
Study of Subretinally Injected ATSN-101 Administered in Patients With Leber Congenital Amaurosis Caused by Biallelic Mutations in GUCY2D
ATSN-101, ATSN-101 Diluent Solution, Prednisone - Leber Congenital Amaurosis, LCA
Phase 1 / Phase 2Active not recruitingAtsena Therapeutics Inc.152019-10-222026-08-03
Efficacy of Oral Antibiotic Therapy Compared to Intravenous Antibiotic Therapy for Osteomyelitis
Intravenous Antibacterial Agent, Oral Antibacterial Agent - Osteomyelitis
Phase 2TerminatedLoyola University302014-03-192018-07-19
Efficacy and Safety Study of Antibiotic Treatment to Treat Hip Prosthetic Joint Infection
VANCOMYCIN, CEFTRIAXONE, CLINDAMYCIN - Hip Prosthetic Joint Infection
Phase 2UnknownUniversity Hospital, Tours1002012-10-012014-05-28
Persistent Methicillin Resistant Staphylococcus Aureus Eradication Protocol (PMEP)
Inhaled Vancomycin, Placebo (Sterile Water), Rifampin - Cystic Fibrosis
Phase 2CompletedJohns Hopkins University292012-10-012019-02-26
Effects of Treatments on Atopic Dermatitis
Trimethoprim/sulfamethoxazole (TMP/SMZ), Cephalexin, Doxycycline - Eczema, Dermatitis
Phase 2RecruitingNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)1302012-09-182026-11-09
The Efficacy of Trimethoprim in Wound Healing of Patients With Epidermolysis Bullosa
Trimethoprim - Epidermolysis Bullosa
Phase 2CompletedThe Hospital for Sick Children102006-09-012018-04-19
Daily Isoniazid to Prevent Tuberculosis in Infants Born to Mothers With HIV
Isoniazid (INH), Trimethoprim/Sulfamethoxazole (TMP/SMX), Isoniazid Placebo (PL) - HIV Infection, Tuberculosis
Phase 2 / Phase 3TerminatedInternational Maternal Pediatric Adolescent AIDS Clinical Trials Group13542004-02-012019-02-05
Combination Immunosuppressive Therapy to Prevent Kidney Transplant Rejection in Adults
Alemtuzumab, Sirolimus, Tacrolimus - Kidney Transplantation, Kidney Disease
Phase 1 / Phase 2CompletedUniversity of Wisconsin, Madison102003-11-012018-06-29
Islet Transplantation for Type 1 Diabetes
Islet Transplantation, Sirolimus, Tacrolimus - Diabetes Mellitus, Insulin-Dependent
Phase 2CompletedNational Institute of Allergy and Infectious Diseases (NIAID)362001-04-012017-03-15
Antimicrobial Solution or Saline Solution in Maintaining Catheter Patency and Preventing Catheter-Related Blood Infections in Patients With Malignancies
Edetate Calcium Disodium, Ethanol, Trimethoprim-sulfamethoxazole - Chronic Myeloproliferative Disorders, Infection
Phase 1 / Phase 2WithdrawnM.D. Anderson Cancer Center2013-02-15

Conditions studied

Blast Crisis (1)  ·  Burkitt Lymphoma (1)  ·  Congenital Abnormalities (1)  ·  Cystic Fibrosis (1)  ·  Dermatitis (1)  ·  Dermatitis, Atopic (1)  ·  Diabetes Mellitus (1)  ·  Diabetes Mellitus, Type 1 (1)  ·  Eczema (1)  ·  Epidermolysis Bullosa (1)  ·  HIV Infections (1)  ·  Hodgkin Disease (1)  ·  Immunoblastic Lymphadenopathy (1)  ·  Immunoglobulin Light-chain Amyloidosis (1)  ·  Infections (1)

Sponsors

Atsena Therapeutics Inc. (1)  ·  International Maternal Pediatric Adolescent AIDS Clinical Trials Group (1)  ·  Johns Hopkins University (1)  ·  Loyola University (1)  ·  M.D. Anderson Cancer Center (1)  ·  Mercy Health Ohio (1)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (1)  ·  National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) (1)  ·  The Hospital for Sick Children (1)  ·  University Hospital, Tours (1)  ·  University of California, San Diego (1)  ·  University of Wisconsin, Madison (1)

Countries

United States (8)  ·  Canada (2)  ·  Italy (2)  ·  Botswana (1)  ·  France (1)  ·  Germany (1)  ·  South Africa (1)  ·  Spain (1)  ·  Switzerland (1)

Top investigators

A. D'jamali, MD, MS (1)  ·  Charles D. Mitchell, MD (1)  ·  Elena Pope, MD (1)  ·  George McSherry, MD (1)  ·  Heidi H Kong, M.D. (1)  ·  James Chmiel, MD (1)  ·  James Shapiro, MD, PhD (1)  ·  Jorge Cortes, MD (1)

Results publications

PMID 15257060, PMID 17005949, PMID 18230259, PMID 20607114, PMID 21732834, PMID 23438305, PMID 26872154, PMID 29654388, PMID 36511181

NIH funding

U01AI068632 (1)